- 14 March
-
At the end of the last year, Novouralsk-based Medsintez Plant turned 20 years old. Alexander Petrov, Chairman of the plant's Board of Directors, told Regions of Russia about the impressive successes that the company has achieved over the years and its ambitious plans for the future.
- 22 January
-
In 2023, the Medsintez Plant, in collaboration with the Promomed Group of Companies, launched the production of a full cycle of hypoglycemic drugs Enligria (liraglutide) and Quincenta (semaglutide) used in treating type II diabetes mellitus, including in patients with obesity and overweight or cardiovascular disease. The preparations are available in the most convenient and familiar for patients dosage form – a disposable prefilled injection and have already been supplied to pharmacies.
- 13 December
-
Medsintez Plant LLC presented the latest biotechnological developments of pharmaceuticals at the largest international scientific and practical forum in the field of medicine and health care Russian Health Care Week — 2023 held from December 4 to December 8 in Moscow. The main purpose of the Forum is to facilitate the implementation of the national projects “Healthcare” and “Demography”, “Tourism and Hospitality Industry”, the federal project “Development of Medical Services Export”, as well as summarizing the results of the Year of Science and Technology in Medicine.
- 04 October
-
On September 27, as part of the business program of the GMP conference with international participation, Alexander Petrov, Chairman of the Board of Directors of Medsintez Plant LLC, took part in a Plenary Session on the issues of regulating the circulation of medicines in Russia and the EAEU, developing import independence, and increasing export potential. The session was attended by representatives of the Ministry of Industry and Trade of the Russian Federation, the Minister of Health of the Republic of Nicaragua, the WHO Representative in Russia, a Representative of the Serbian Ministry of Health and other Russian and foreign experts. Mr. Petrov spoke about the problems that Russian pharmaceutical companies face when entering international markets and suggested possible solutions.
- Home
- Cluster members
- RASTER LLC
RASTER LLC
RASTER LLC develops, manufactures and sells high quality disinfectants (in liquid, granular and tablet form), skin antiseptics and liquid soap. It also produces aerosol equipment for volumetric disinfection. RASTER LLC is part of the RASTER group of companies along with other enterprises: DEO LLC, Firma Raster LLC, DESAN LLC.
The RASTER group of companies has been specializing in the field of commercial sanitation since 1991 During this time, RASTER has become a major wholesale supplier of modern disinfectants, primarily for healthcare institutions, enterprises of collective users and food industry (dairy, meat, brewing). Along with disinfectants for professional use, the group of companies produces and markets household chemicals under the SANITEKA brand. The enterprises of the group of companies are holders of the Certificate of Conformity of the Quality Management System (QMS) with the international requirements of ISO 9001:2015.
RASTER LLC is a manufacturer of a wide range of disinfectants and equipment for volumetric disinfection. The company has been a member of the National Organization of Disinfectionists since 1994 and a member of the National Association of the Specialistsin Control of Health Care-Associated Infections (NASKI). The company is also a distributor of Hygiène et Nature (France) in the Russian Federation and CIS countries. The RASTER group of companies does not stop there, constantly improving the accumulated cleanliness technologies. RASTER proved that the systematic use of inexpensive, modern, resource-saving products gives a high economic and social effect.
15, Kluchevskaya St, Ekaterinburg, 620109
Tel.: +7 (343) 380-49-80
Email: hello@raster.ru
www.raster.ru
